Sorry, you need to enable JavaScript to visit this website.

Hasta aquí, todo bien...

Al parecer reúne los requisitos básicos para este estudio de la COVID-19. Sin embargo, solo el personal del estudio de investigación puede determinar plenamente si reúne los requisitos para inscribirse. Ingrese su información de contacto y seleccione "Buscar un centro" para ver si hay un centro del estudio inscribiendo en su zona.

Hasta aquí, todo bien...

Parece que su hijo cumple los requisitos básicos para este estudio de la vacuna contra la COVID-19. Sin embargo, solo el personal del estudio de investigación podrá determinar completamente si su hijo reúne los requisitos para inscribirse. Introduzca su información de contacto y seleccione “Encontrar un centro” para ver si hay un centro del estudio inscribiendo participantes en su zona.

Nota: Los padres de familia y tutores deben introducir su información de contacto, no la de su hijo.

Lo sentimos, usted no es elegible en este momento...

Muchas gracias por su interés en el estudio de la COVID-19 y por responder nuestras preguntas. Considere volver a COVIDPillStudy.com para ver si otro estudio sobre la COVID-19 puede ser más adecuado para usted. También puede ingresar su información a continuación si desea que se comuniquen con usted acerca de las oportunidades de estudios clínicos futuros. Comuníquese con su proveedor de atención médica si tiene alguna pregunta médica.

Lo sentimos, su hijo no es elegible en este momento...

Gracias por su interés en este estudio de la vacuna contra la COVID-19 y por responder nuestras preguntas. Comuníquese con su proveedor de atención médica si tiene alguna pregunta médica. Además, considere ingresar su información a continuación para que se comuniquen con usted acerca de las oportunidades de estudios de investigación futuros.

A Clinical Study for Household Members of Those Recently Diagnosed

A COVID-19 clinical study is underway to evaluate the safety and effectiveness of a possible preventative treatment for adults living in the same home with someone recently diagnosed with COVID-19 and showing symptoms. Answer a few questions to see if you may be able to participate.

Now Enrolling

Header

Pregunta 1 de 4

¿Tiene al menos 18 años de edad?

SÍ
No

Pregunta 2 de 4

Was a member of your household diagnosed with COVID-19 in the last 4 days?

SÍ
No

Pregunta 3 de 4

Do you currently have any symptoms of COVID-19?

SÍ
No

Pregunta 4 de 4

Have you previously tested positive for COVID-19?

SÍ
No
manual address entry
Por favor seleccione una dirección válida completa.

Elegir una ubicación

Seleccione un centro de investigación cerca de usted. Si no ve ningún centro cerca de usted, seleccione "Los centros mencionados aquí no son convenientes para mí". Se añaden con regularidad ubicaciones del estudio. Un representante del estudio le llamará cuando esté disponible un centro de investigación en su área.

Los centros mencionados aquí no son convenientes para mí.

ABOUT THE COVID-19 STUDY FOR HOUSEHOLD MEMBERS OF THOSE RECENTLY DIAGNOSED

This study is evaluating whether an investigational drug is safe and effective in preventing COVID-19 in adults living in the same home with someone already diagnosed and showing symptoms. If you have recently been exposed to COVID-19 by a household member, participation can be an option to consider not only for yourself, but as an important contribution to the global effort to move beyond COVID-19.

Who May Participate

Joining a clinical trial is an important and personal decision. Thank you for considering this study.

This study may be an option for you if you are at least 18 years old and meet all the requirements below:

  • A member of your household was diagnosed with COVID-19 in the last 4 days and has at least one symptom of COVID-19.
  • You do not currently have any symptoms of COVID-19.
  • You have never tested positive for COVID-19.
  • You have not received and do not plan to receive a COVID-19 vaccine during the study period.

Note: These are not the only eligibility criteria for this clinical study. A study team member will help determine if this study is right for you based on all participation criteria.

Header Image

What to Expect

This study involves comparing an investigational (study) drug against a placebo (tablet or capsule with no active ingredient). Placebos are an important part of the clinical research process by providing researchers with a point of comparison to know if a study drug is safe and effective. We learn about the effectiveness and safety of the study drug by comparing the experiences of the participants who receive the study drug to those who receive the placebo.

Your participation in the study will last about 6 weeks. Here’s how the study will work:

A computer will randomly assign you to receive the study drug, the placebo, or a combination of both. Neither you nor the study doctor will know if you are receiving the study drug, placebo, or combination.

You will take 2 oral tablets and 1 capsule twice a day for 10 days, for a total of 20 doses. The first dose may be taken at the study site. The remaining 19 doses will be taken at home every 12 hours.

Over approximately 6 weeks, you will have 6 to 9 visits with the study team, either in-person or by telemedicine (over the telephone or computer). You will be asked to track any changes in your health in an electronic diary (e-diary). You will also be asked to self-collect nasal swabs daily at home for the first 2 weeks.

Header Image